{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:54:07Z","timestamp":1792176847991,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3M0101-3"],"award-info":[{"award-number":["CIRPG3M0101-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20703"],"award-info":[{"award-number":["U24A20703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130089"],"award-info":[{"award-number":["82130089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2326B-182A-001"],"award-info":[{"award-number":["113-2326B-182A-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2811B-182A-010"],"award-info":[{"award-number":["114-2811B-182A-010"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2628B-182A-003-MY3"],"award-info":[{"award-number":["114-2628B-182A-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320B-182A-003-MY3"],"award-info":[{"award-number":["NSTC 113-2320B-182A-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023AFB1024"],"award-info":[{"award-number":["2023AFB1024"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.05.042","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:48:24Z","timestamp":1779292104000},"page":"670-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A distinct psoriasis\u2013atopic dermatitis overlapping phenotype in adults with dual type 2 and type 3 immune features and favorable response to Janus kinase 1 inhibition"],"prefix":"10.1016","volume":"95","author":[{"given":"Mengjiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Huei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline","family":"Chung-Yee Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-6649","authenticated-orcid":false,"given":"Juan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.05.042_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaad.2026.05.042_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.05.042_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.05.042_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0140-6736(22)02347-9","article-title":"Long-term disease control in atopic dermatitis using biologics","volume":"401","author":"Thyssen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.05.042_bib6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/all.70026","article-title":"Elevated cutaneous interleukin-21 links eczematous eruption to interleukin-17A inhibitor treatment in psoriasis","volume":"81","author":"Zhang","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2026.05.042_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Al-Janabi","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamadermatol.2025.1578","article-title":"Psoriasis risk in patients with atopic dermatitis treated with dupilumab","volume":"161","author":"Lin","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jid.2022.10.015","article-title":"IL-4\/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis","volume":"143","author":"Grolleau","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/bjd\/ljac097","article-title":"Validation of diagnostic criteria for atopic dermatitis and proposal of novel diagnostic criteria for adult and elderly Chinese populations: a multicentre, prospective, clinical setting-based study","volume":"188","author":"Yue","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jdin.2024.03.028","article-title":"Characterization of atopic dermatitis in older adults: a retrospective study","volume":"16","author":"Wang","year":"2024","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.05.042_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib13","first-page":"445","article-title":"Eczematized psoriasis \u2013 a frequent but often neglected variant of plaque psoriasis","volume":"21","author":"Lauffer","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2026.05.042_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamadermatol.2015.2","article-title":"Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis","volume":"151","author":"Moy","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamadermatol.2023.2626","article-title":"Safety and efficacy of tralokinumab in older adults with moderate-to-severe atopic dermatitis: a secondary analysis","volume":"159","author":"Merola","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90105-w","article-title":"Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2\/Th17-centered cutaneous immune activation","volume":"11","author":"Wongvibulsin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaad.2026.05.042_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?","volume":"48","author":"Guttman-Yassky","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/09546634.2019.1702147","article-title":"Concomitant atopic dermatitis and psoriasis - a retrospective review","volume":"32","author":"Barry","year":"2021","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2026.05.042_bib19","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1002\/ski2.29","article-title":"Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis","volume":"1","author":"Cunliffe","year":"2021","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jaad.2026.05.042_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.023","volume":"82","author":"Cohen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.05.042_bib22","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/DER.0000000000000645","article-title":"Concurrent atopic dermatitis and psoriasis successfully treated with brodalumab","volume":"32","author":"Gambardella","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2026.05.042_bib23","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.3390\/ijms23105518","article-title":"Overlapping features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes","volume":"23","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2026.05.042_bib24","article-title":"Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1540-9740.2005.03636.x","article-title":"PsEma--a hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema","volume":"4","author":"Abramovits","year":"2005","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2026.05.042_bib26","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.15213","article-title":"Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children","volume":"33","author":"Kouwenhoven","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.042_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jid.2023.12.023","article-title":"GRP78 downregulation in keratinocytes promotes skin inflammation through the recruitment and activation of CCR6+ IL-17A\u2013producing \u03b3\u03b4 T cells","volume":"144","author":"Zhao","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2340\/00015555-2779","article-title":"Eczema in psoriatico: an important differential diagnosis between chronic allergic contact dermatitis and psoriasis in palmoplantar localization","volume":"98","author":"Kolesnik","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.05.042_bib29","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3390\/diagnostics12123071","article-title":"Palmoplantar psoriasis: a clinico-pathologic study on a series of 21 cases with emphasis on differential diagnosis","volume":"12","author":"Broggi","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.jaad.2026.05.042_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/bjd\/ljae430","article-title":"A case of biologic-resistant hand dermatitis demonstrates dual T2\/T17 transcriptomic abnormalities and responds to janus kinase inhibition","volume":"192","author":"Taylor","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/biomedicines10071485","article-title":"Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases","volume":"10","author":"Miyagawa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaad.2026.05.042_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/all.15486","article-title":"Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis","volume":"78","author":"Zhang","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2026.05.042_bib33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/eji.202048627","article-title":"Tc17 biology and function: novel concepts","volume":"50","author":"L\u00fcckel","year":"2020","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.170.1.613","article-title":"IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age","volume":"170","author":"Schwaiger","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","article-title":"CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells","volume":"145","author":"Feng","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2026.05.042_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/bjd\/ljac016","article-title":"Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies","volume":"188","author":"Trier","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib37","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2022.07.003","article-title":"TSLP, IL-33, and IL-25: not just for allergy and helminth infection","volume":"150","author":"Stanbery","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S441100","article-title":"Microbiome: role in inflammatory skin diseases","volume":"17","author":"Zhang","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jaad.2026.05.042_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib40","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/cells13161398","article-title":"IL-22 in atopic dermatitis","volume":"13","author":"Laska","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jaad.2026.05.042_bib41","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/s41467-024-46540-0","article-title":"Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells","volume":"15","author":"Bangert","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2026.05.042_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.anai.2023.01.020","article-title":"Oral Janus kinase inhibitors for atopic dermatitis","volume":"130","author":"Mikhaylov","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/pharmaceutics15020385","article-title":"Efficacy and safety of JAK1 inhibitor abrocitinib in atopic dermatitis","volume":"15","author":"Iznardo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaad.2026.05.042_bib44","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/jcm10091906","article-title":"Interleukin-31 and pruritic skin","volume":"10","author":"Furue","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2026.05.042_bib45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaad.2026.05.042_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-025-03591-4","article-title":"STAT3 S727 phosphorylation drives pathogenic Th17 differentiation and neuroinflammation in autoimmune disease","volume":"22","author":"Prado","year":"2025","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jaad.2026.05.042_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175276","article-title":"Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model","volume":"933","author":"Tang","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaad.2026.05.042_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114513","article-title":"IL-17 enhanced the susceptibility to fluoxetine resistance in depression via the JAK1-STAT6 signaling pathway","volume":"155","author":"Zhang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaad.2026.05.042_bib49","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0140-6736(21)00589-4","article-title":"Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD up): results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Reich","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.05.042_bib50","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(21)00588-2","article-title":"Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (measure up 1 and measure up 2): results from two replicate double-blind, randomised controlled phase 3 trials","volume":"397","author":"Guttman-Yassky","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.05.042_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.05.042_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17742","article-title":"Rapid clinical improvement with tyrosine kinase 2 inhibitor deucravacitinib in overlapping psoriasis and atopic dermatitis","volume":"64","author":"Tang","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/ijd.17512","article-title":"Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series","volume":"64","author":"Carlos","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.042_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdcr.2024.05.009","article-title":"Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series","volume":"49","author":"Shahriari","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2026.05.042_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2183729","article-title":"Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series","volume":"34","author":"Gargiulo","year":"2023","journal-title":"J Dermatol Treat"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226027209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226027209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:41:48Z","timestamp":1787139708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226027209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0190962226027209"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A distinct psoriasis\u2013atopic dermatitis overlapping phenotype in adults with dual type 2 and type 3 immune features and favorable response to Janus kinase 1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}